Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Asthma and respiratory diseases, Respiratory and Cough-Related Research, Allergic Rhinitis and Sensitization, and IL-33, ST2, and ILC Pathways.
Inflammatory Pathways in Residual Asthma Exacerbations Among Mepolizumab-Treated Urban Children
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma
A systematic literature review of rhinovirus infection in adults with asthma
Activated sputum eosinophils associated with exacerbations in children on mepolizumab
Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 Continents
Long-Term Dupilumab Efficacy on Severe Exacerbations and Lung Function in Patients with Type 2 Asthma
Associations between outdoor air pollutants and non-viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy
Rhinoviruses A and C elicit long‐lasting antibody responses with limited cross‐neutralization
Dupilumab Reduces Exacerbations And Improves Lung Function Regardless Of Prior Asthma Exacerbation Status: LIBERTY ASTHMA TRAVERSE Open-Label Extension Study
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial
Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma
Seasonal airway microbiome and transcriptome interactions promote childhood asthma exacerbations
Current unmet needs and potential solutions to uncontrolled asthma
Holy Grail: the journey towards disease modification in asthma
Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation
Benefits of Airway Androgen Receptor Expression in Human Asthma
What is the contribution of IgE to nasal polyposis?
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment
Inducible expression quantitative trait locus analysis of the MUC5AC gene in asthma in urban populations of children
Association of mold levels in urban children’s homes with difficult-to-control asthma
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
Type 2 immunity in the skin and lungs
Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis
Expression quantitative trait locus fine mapping of the 17q12–21 asthma locus in African American children: a genetic association and gene expression study
<i>HSD3B1</i> genotype identifies glucocorticoid responsiveness in severe asthma
Serum IL-6: A biomarker in childhood asthma?
Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection
Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent Asthma